230 related articles for article (PubMed ID: 17957129)
21. Arsenic trioxide induces multiple myeloma cell apoptosis via disruption of mitochondrial transmembrane potentials and activation of caspase-3.
Jia P; Chen G; Huang X; Cai X; Yang J; Wang L; Zhou Y; Shen Y; Zhou L; Yu Y; Chen S; Zhang X; Wang Z
Chin Med J (Engl); 2001 Jan; 114(1):19-24. PubMed ID: 11779429
[TBL] [Abstract][Full Text] [Related]
22. Realgar (As4S4) nanoparticles and arsenic trioxide (As2O3) induced autophagy and apoptosis in human melanoma cells in vitro.
Pastorek M; Gronesova P; Cholujova D; Hunakova L; Bujnakova Z; Balaz P; Duraj J; Lee TC; Sedlak J
Neoplasma; 2014; 61(6):700-9. PubMed ID: 25150315
[TBL] [Abstract][Full Text] [Related]
23. Suppression of arsenic trioxide-induced apoptosis in HeLa cells by N-acetylcysteine.
Han YH; Kim SZ; Kim SH; Park WH
Mol Cells; 2008 Jul; 26(1):18-25. PubMed ID: 18511884
[TBL] [Abstract][Full Text] [Related]
24. Antitumor effects of arsenic trioxide in transformed human thyroid cells.
Fröhlich E; Czarnocka B; Brossart P; Wahl R
Thyroid; 2008 Nov; 18(11):1183-93. PubMed ID: 19014326
[TBL] [Abstract][Full Text] [Related]
25. Arsenic trioxide induces apoptosis in uveal melanoma cells through the mitochondrial pathway.
Chen MJ; Yang PY; Ye YZ; Hu DN; Chen MF
Am J Chin Med; 2010; 38(6):1131-42. PubMed ID: 21061466
[TBL] [Abstract][Full Text] [Related]
26. Dithiothreitol abrogates the effect of arsenic trioxide on normal rat liver mitochondria and human hepatocellular carcinoma cells.
Paul MK; Kumar R; Mukhopadhyay AK
Toxicol Appl Pharmacol; 2008 Jan; 226(2):140-52. PubMed ID: 18022205
[TBL] [Abstract][Full Text] [Related]
27. Arsenic trioxide and cisplatin synergism increase cytotoxicity in human ovarian cancer cells: therapeutic potential for ovarian cancer.
Zhang N; Wu ZM; McGowan E; Shi J; Hong ZB; Ding CW; Xia P; Di W
Cancer Sci; 2009 Dec; 100(12):2459-64. PubMed ID: 19769630
[TBL] [Abstract][Full Text] [Related]
28. Potentiation of arsenic trioxide cytotoxicity by Parthenolide and buthionine sulfoximine in murine and human leukemic cells.
Duechler M; Stańczyk M; Czyz M; Stepnik M
Cancer Chemother Pharmacol; 2008 Apr; 61(5):727-37. PubMed ID: 17594095
[TBL] [Abstract][Full Text] [Related]
29. Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor kappaB.
Wei LH; Lai KP; Chen CA; Cheng CH; Huang YJ; Chou CH; Kuo ML; Hsieh CY
Oncogene; 2005 Jan; 24(3):390-8. PubMed ID: 15531921
[TBL] [Abstract][Full Text] [Related]
30. Arsenic trioxide induces apoptosis equally in T lymphoblastoid leukemia MOLT-4 cells and P-gp-expressing daunorubicin-resistant MOLT-4 cells.
Hu XM; Hirano T; Oka K
Cancer Chemother Pharmacol; 2003 Feb; 51(2):119-26. PubMed ID: 12647012
[TBL] [Abstract][Full Text] [Related]
31. Arsenic trioxide induced the apoptosis of laryngeal cancer via down-regulation of survivin mRNA.
Cheng B; Yang X; Han Z; An L; Liu S
Auris Nasus Larynx; 2008 Mar; 35(1):95-101. PubMed ID: 17869043
[TBL] [Abstract][Full Text] [Related]
32. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines.
Ramos AM; Aller P
Biochem Pharmacol; 2008 May; 75(10):1912-23. PubMed ID: 18359480
[TBL] [Abstract][Full Text] [Related]
33. Different pathways are involved in arsenic-trioxide-induced cell proliferation and growth inhibition in human keratinocytes.
Bi X; Gu J; Guo Z; Tao S; Wang Y; Tang L; Wu J; Mi Q
Skin Pharmacol Physiol; 2010; 23(2):68-78. PubMed ID: 20016248
[TBL] [Abstract][Full Text] [Related]
34. Inhibition on LS-174T cell growth and activity of telomerase in vitro and in vivo by arsenic trioxide.
Wang X; Wang G; Dong D; Fu S; Yang B
Exp Toxicol Pathol; 2008 Sep; 60(6):481-8. PubMed ID: 18606528
[TBL] [Abstract][Full Text] [Related]
35. Induction of apoptosis and inhibition of telomerase activity by arsenic trioxide (As2O3) in endometrial carcinoma cells.
Zhou C; Boggess JF; Bae-Jump V; Gehrig PA
Gynecol Oncol; 2007 Apr; 105(1):218-22. PubMed ID: 17275888
[TBL] [Abstract][Full Text] [Related]
36. Targeted degradation of the AML1/MDS1/EVI1 oncoprotein by arsenic trioxide.
Shackelford D; Kenific C; Blusztajn A; Waxman S; Ren R
Cancer Res; 2006 Dec; 66(23):11360-9. PubMed ID: 17145882
[TBL] [Abstract][Full Text] [Related]
37. Apoptosis induction by (+)alpha-tocopheryl succinate in the absence or presence of all-trans retinoic acid and arsenic trioxide in NB4, NB4-R2 and primary APL cells.
Freitas RA; Silva dos Santos GA; Gimenes Teixeira HL; Scheucher PS; Lucena-Araujo AR; Lima AS; Abreu e Lima RS; Garcia AB; Jordão AA; Falcão RP; Vannucchi H; Rego EM
Leuk Res; 2009 Jul; 33(7):958-63. PubMed ID: 19013639
[TBL] [Abstract][Full Text] [Related]
38. Effect of arsenic trioxide on multidrug resistant hepatocellular carcinoma cells.
Chan JY; Siu KP; Fung KP
Cancer Lett; 2006 May; 236(2):250-8. PubMed ID: 15982806
[TBL] [Abstract][Full Text] [Related]
39. Morphologic and functional alterations induced by low doses of mercuric chloride in the kidney OK cell line: ultrastructural evidence for an apoptotic mechanism of damage.
Carranza-Rosales P; Said-Fernández S; Sepúlveda-Saavedra J; Cruz-Vega DE; Gandolfi AJ
Toxicology; 2005 Jun; 210(2-3):111-21. PubMed ID: 15840425
[TBL] [Abstract][Full Text] [Related]
40. Ezrin, actin and cytoskeleton in apoptosis of esophageal epithelial cells induced by arsenic trioxide.
Shen ZY; Xu LY; Li EM; Li JT; Chen MH; Shen J; Zeng Y
Int J Mol Med; 2003 Sep; 12(3):341-7. PubMed ID: 12883650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
